These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29499462)

  • 1. Identification, characterization and HPLC quantification of formulation-related impurities of honokiol, an antitumor natural drug candidate in clinical trials.
    Wu W; Tang MH; Tang H; Chen K; Fu J; Wang L; Xue LL; Peng A; Ye H; Chen LJ
    J Pharm Biomed Anal; 2018 May; 153():186-192. PubMed ID: 29499462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assessment of commercial Magnoliae officinalis Cortex by ¹H-NMR-based metabolomics and HPLC methods.
    Jiang Y; Vaysse J; Gilard V; Balayssac S; Déjean S; Malet-Martino M; David B; Fiorini C; Barbin Y
    Phytochem Anal; 2012; 23(4):387-95. PubMed ID: 22025447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of honokiol after intravenous guttae in beagle dogs assessed using ultra-performance liquid chromatography-tandem mass spectrometry.
    Liang Y; Cui G; Wang X; Zhang W; An Q; Lin Z; Wang H; Chen S
    Biomed Chromatogr; 2014 Oct; 28(10):1378-83. PubMed ID: 24652775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of honokiol and magnolol in Magnolia officinalis by liquid chromatography with tandem mass spectrometric detection.
    Wu YT; Lin LC; Tsai TH
    Biomed Chromatogr; 2006 Oct; 20(10):1076-81. PubMed ID: 16583454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR.
    Liu L; Cao N; Ma X; Xiong K; Sun L; Zou Q; Yao L
    J Pharm Biomed Anal; 2016 Jan; 117():325-32. PubMed ID: 26412721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated ultra-HPLC-MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study.
    Zhuang Q; Pan R; Liu X; Xu W; Wang H; Zhang X; Lai X; Wang H; Zhang L; Jiang J
    Bioanalysis; 2019 Jun; 11(11):1085-1098. PubMed ID: 31251102
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan.
    Hu DD; Han QB; Zhong LL; Li YH; Lin CY; Ho HM; Zhang M; Lin SH; Zhao L; Huang T; Mi H; Tan HS; Xu HX; Bian ZX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():136-46. PubMed ID: 26231677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of counter-current chromatography and preparative high performance liquid chromatography applied to separating minor impurities in drug preparations.
    Li S; Wang W; Tang H; Chen K; Yang J; He L; Ye H; Peng A; Chen L
    J Chromatogr A; 2014 May; 1344():51-8. PubMed ID: 24767948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of honokiol derivatives from one-pot synthesis by high-performance counter-current chromatography.
    Shi J; Xu G; Peng A; Peng M; Ye H; Zhong S; He S; Li S; Luo Y; Wei Y; Chen L
    J Chromatogr A; 2010 May; 1217(20):3461-5. PubMed ID: 20388568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
    Liu M; Wang J; Liu P
    J Pharm Biomed Anal; 2016 Nov; 131():429-435. PubMed ID: 27661436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776).
    Wang J; Liu M; Yang C; Wu X; Wang E; Liu P
    J Pharm Biomed Anal; 2016 May; 124():267-273. PubMed ID: 26970596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of metabolites of honokiol in rat urine using 13C stable isotope labeling and liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
    Liu J; Tang M; Lai H; Dong Y; Xie C; Ye H; Ma L; Qiu N; Li Y; Cai L; Chen L
    J Chromatogr A; 2013 Jun; 1295():48-56. PubMed ID: 23618226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
    Zhang H; Sun L; Zou L; Hui W; Liu L; Zou Q; Ouyang P
    J Pharm Biomed Anal; 2016 Sep; 128():18-27. PubMed ID: 27209451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparative purification of anti-tumor derivatives of honokiol by high-speed counter-current chromatography.
    Luo Y; Xu Y; Chen L; Luo H; Peng C; Fu J; Chen H; Peng A; Ye H; Xie D; Fu A; Shi J; Yang S; Wei Y
    J Chromatogr A; 2008 Jan; 1178(1-2):160-5. PubMed ID: 18082756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transglycosylation of neolignans by enzymatic synthesis and evaluation of their antitumor activity].
    Li H; Li J; Jin W; Guo X; Li N; Ma T; Huo Q; Wu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1570-4. PubMed ID: 26607077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
    Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity.
    Lacroix PM; Dawson BA; Sears RW; Black DB; Cyr TD; Ethier JC
    J Pharm Biomed Anal; 1998 Nov; 18(3):383-402. PubMed ID: 10096833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.